Capsaicin is believed to act on a substance in the body which is involved in transmission of pain impulses, known as Substance P.
It is believed that regular application of capsaicin (Zostrix) to the affected area will in time reduce the amount of Substance P in nearby nerve endings. With less of Substance P present, pain may be less intense and in some cases there may be a cessation of pain.
Zostrix cream contains capsaicin 0.025% w/w and is supplied in tubes of 45g.
May be useful as an adjunct in the temporary relief of pain associated with arthritis. May be useful for the treatment of post-herpetic neuralgia (pain following shingles).
For external use only:
Avoid contact with eyes and broken or irritated skin. If condition worsens, or if symptoms persist for more than 28 days in the case of arthritis (14 days with post-herpetic neuralgia) or clear up and occur again within a few
days, discontinue use of this product and consult your doctor. Keep out of the reach of children.
Adults and children 2 years of age and older:
Apply Zostrix to affected area 3 to 4 times daily. Zostrix may cause temporary burning when applied.
This burning is observed more frequently if Zostrix is used less than 3 times a day. Unless treating hands, wash hands thoroughly with soap and water after application. If Zostrix is found to irritate fingers, a disposable glove
or finger cot may be used for Zostrix application.
After rubbing in Zostrix as completely as possible, any excess cream may be gently removed with a disposable
LINK Healthcare is a privately owned Australian-based specialist Pharmaceutical and Medical Technology business. LINK's mission is to strive for excellence in the marketing of a vitally important and unique range of specialist products that enhance the well-being of thousands of people in the region.
LINK provides exceptional sales and marketing infrastructure and is partnered with blue chip pharmaceutical companies from around the world, allowing the company to offer a unique and substantial portfolio of'medicine that matters.'
At LINK Healthcare we focus on specialist pharmaceutical products and medical devices. Our pharmaceutical range consists of both proprietary and in-licensed products. While seeking the development and acquisition of our own products, we are also committed to building lasting ongoing relationships with partner companies around the world. Our substantial infrastructure and breadth of experience means that partner products become firmly embedded within our existing range as well as in the markets in which we operate.
Our partners are a wide variety of pharmaceutical businesses which are interested in streamlining their distribution and marketing, or expanding their business with a single organisation covering our entire region of Australia, New Zealand, South Africa or South East Asia.